Literature DB >> 7859201

Supplementary statement on newly licensed Haemophilus influenzae type B (Hib) conjugate vaccines in combination with other vaccines recommended for infants.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7859201      PMCID： PMC1337707     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group.

Authors:  S B Black; H R Shinefield; P Ray; E M Lewis; B Fireman; R Hiatt; D V Madore; C L Johnson; J G Hackell
Journal:  Pediatr Infect Dis J       Date:  1993-12       Impact factor: 2.129

2.  Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants.

Authors:  P R Paradiso; D A Hogerman; D V Madore; H Keyserling; J King; K S Reisinger; M M Blatter; E Rothstein; H H Bernstein; J Hackell
Journal:  Pediatrics       Date:  1993-12       Impact factor: 7.124

3.  Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age.

Authors:  R Gold; D Scheifele; L Barreto; S Wiltsey; G Bjornson; W Meekison; R Guasparini; L Medd
Journal:  Pediatr Infect Dis J       Date:  1994-05       Impact factor: 2.129
  3 in total
  1 in total

1.  Population-based surveillance of Hib invasive infections in children in British Columbia Alberta and Ontario - 1995 to 1997.

Authors:  D Scheifele; A Bell; T Jadavji; W Vaudry; J Waters; M Naus; J Sciberras
Journal:  Can J Infect Dis       Date:  2000-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.